Definitive Contract #75F40126C00101

Multi-Year Research Contract with University of Strathclyde for Pediatric Bioequivalence Enhancement

This definitive contract represents a significant multi-year agreement awarded to the University of Strathclyde, a respected academic institution in the United Kingdom. The contract focuses on advancing regulatory confidence in pediatric bioequivalence by developing and validating time-based mechanistic platforms combined with model-integrated evidence. The scope entails innovative research efforts aimed at improving the scientific basis for pediatric drug equivalence assessments, which holds important implications for healthcare regulation and public health outcomes. This award was given through a Broad Agency Announcement process, reflecting a competitive selection for specialized scientific research expertise. The contract covers a timeline spanning several years, with performance expected to continue for four to five years from the award date. The work is to be performed in Great Britain, underscoring the international collaboration in this health science domain. Although subcontractor and vehicle details are not specified, this award highlights the critical role of academic research institutions in supporting government health and regulatory agencies through focused scientific investigations.

Description

4 YEAR BAA CONTRACT- FY26C1AP5-ENHANCING REGULATORY CONFIDENCE IN PEDIATRIC BIOEQUIVALENCE THROUGH VALIDATED TIM BASED MECHANISTIC PLATFORMS AND MODEL INTEGRATED EVIDENCE

View original record